ACRS: Aclaris Therapeutics, Inc. Stock

by  •  • Comments Off on ACRS: Aclaris Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 174.29
Enterprise Value ($M) 126.64
Book Value ($M) 130.15
Book Value / Share 1.82
Price / Book 1.34
NCAV ($M) 80.09
NCAV / Share 1.12
Price / NCAV 2.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.24

Liquidity (mrq)
Quick Ratio 7.03
Current Ratio 7.03

Balance Sheet (mrq) ($M)
Current Assets 132.33
Assets 182.39
Liabilities 52.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
1 day ago 13G/A Citadel Advisors Llc 0.50
10-09 13G/A Millennium Management Llc 4.20 -20.27
07-08 13G/A BlackRock Inc. 2.90 -65.59
02-14 13G/A Rock Springs Capital Management LP 4.23 -24.30
02-14 13G/A Biotechnology Value Fund L P 0.00 -100.00
02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 0.00 -100.00
02-14 13G/A Ra Capital Management, L.p. 0.00 -100.00
02-14 13G/A Tang Capital Partners Lp 2.50 -59.58
02-13 13G/A Foresite Capital Fund IV, L.P. 0.00 -100.00
02-13 13G Vanguard Group Inc 6.67
02-08 13G/A BML Investment Partners, L.P. 13.30 108.80
12-11 13G/A Wellington Management Group Llp 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-14 45,009 1,139,526 3.95
2024-11-13 28,543 530,674 5.38
2024-11-12 34,441 508,897 6.77
2024-11-11 335,282 1,739,329 19.28

(click for more detail)

Similar Companies
ABUS – Arbutus Biopharma Corporation ACAD – ACADIA Pharmaceuticals Inc.
ACLX – Arcellx, Inc. ACT – Enact Holdings, Inc.
ADPT – Adaptive Biotechnologies Corporation


Financial data and stock pages provided by
Fintel.io